Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1993 Jun;35(6):557–563. doi: 10.1111/j.1365-2125.1993.tb04181.x

The treatment of heart failure--what next?

R H Davies 1, D J Sheridan 1
PMCID: PMC1381595  PMID: 8329279

Abstract

1. Despite demonstrable benefits in terms of symptomatic relief and improvement in prognosis, even the best treatments of heart failure currently available fall short of being ideal. We review the basis for newer approaches to the treatment of heart failure and discuss some of the agents which capitalize on current understanding of the underlying patho-physiology. 2. Several drugs, old and new, are presently being investigated by major clinical trials. We also consider some of the difficulties related to the design and conduct of such trials and suggest how drugs might be better assessed in the future.

Full text

PDF
557

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. L., Gilbert E. M., O'Connell J. B., Renlund D., Yanowitz F., Murray M., Roskelley M., Mealey P., Volkman K., Deitchman D. Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1991 May;17(6):1373–1381. doi: 10.1016/s0735-1097(10)80150-0. [DOI] [PubMed] [Google Scholar]
  2. Aroney C. N., Semigran M. J., Dec G. W., Boucher C. A., Fifer M. A. Inotropic effect of nicardipine in patients with heart failure: assessment by left ventricular end-systolic pressure-volume analysis. J Am Coll Cardiol. 1989 Nov 1;14(5):1331–1338. doi: 10.1016/0735-1097(89)90437-3. [DOI] [PubMed] [Google Scholar]
  3. Asmar R. G., Pannier B., Santoni J. P., Laurent S., London G. M., Levy B. I., Safar M. E. Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation. 1988 Oct;78(4):941–950. doi: 10.1161/01.cir.78.4.941. [DOI] [PubMed] [Google Scholar]
  4. Binkley P. F., Van Fossen D. B., Nunziata E., Unverferth D. V., Leier C. V. Influence of positive inotropic therapy on pulsatile hydraulic load and ventricular-vascular coupling in congestive heart failure. J Am Coll Cardiol. 1990 Apr;15(5):1127–1135. doi: 10.1016/0735-1097(90)90253-l. [DOI] [PubMed] [Google Scholar]
  5. Bristow M. R., Ginsburg R., Minobe W., Cubicciotti R. S., Sageman W. S., Lurie K., Billingham M. E., Harrison D. C., Stinson E. B. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982 Jul 22;307(4):205–211. doi: 10.1056/NEJM198207223070401. [DOI] [PubMed] [Google Scholar]
  6. Brodde O. E. Physiology and pharmacology of cardiovascular catecholamine receptors: implications for treatment of chronic heart failure. Am Heart J. 1990 Dec;120(6 Pt 2):1565–1572. doi: 10.1016/0002-8703(90)90060-b. [DOI] [PubMed] [Google Scholar]
  7. Brown J. J., Davies D. L., Johnson V. W., Lever A. F., Robertson J. I. Renin relationships in congestive cardiac failure, treated and untreated. Am Heart J. 1970 Sep;80(3):329–342. doi: 10.1016/0002-8703(70)90098-0. [DOI] [PubMed] [Google Scholar]
  8. Burstein S., Semigran M. J., Dec G. W., Jr, Boucher C. A., Fifer M. A. Positive inotropic and lusitropic effects of intravenous flosequinan in patients with heart failure. J Am Coll Cardiol. 1992 Oct;20(4):822–829. doi: 10.1016/0735-1097(92)90179-q. [DOI] [PubMed] [Google Scholar]
  9. Cody R. J., Atlas S. A., Laragh J. H., Kubo S. H., Covit A. B., Ryman K. S., Shaknovich A., Pondolfino K., Clark M., Camargo M. J. Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest. 1986 Nov;78(5):1362–1374. doi: 10.1172/JCI112723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  11. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  12. Cohn J. N., Levine T. B., Olivari M. T., Garberg V., Lura D., Francis G. S., Simon A. B., Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984 Sep 27;311(13):819–823. doi: 10.1056/NEJM198409273111303. [DOI] [PubMed] [Google Scholar]
  13. Cowley A. J., Stainer K., Rowley J. M., Hampton J. R. Abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure. Br Heart J. 1986 Jan;55(1):75–80. doi: 10.1136/hrt.55.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Culling W., Ruttley M. S., Sheridan D. J. Acute haemodynamic effects of felodipine during beta blockade in patients with coronary artery disease. Br Heart J. 1984 Oct;52(4):431–434. doi: 10.1136/hrt.52.4.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dei Cas L., Metra M., Nodari S., Visioli O. Efficacy of ibopamine treatment in patients with advanced heart failure: purpose of a new therapeutic scheme with multiple daily administrations. J Cardiovasc Pharmacol. 1989;14 (Suppl 8):S111–S117. [PubMed] [Google Scholar]
  16. Drexler H., Faude F., Höing S., Just H. Blood flow distribution within skeletal muscle during exercise in the presence of chronic heart failure: effect of milrinone. Circulation. 1987 Dec;76(6):1344–1352. doi: 10.1161/01.cir.76.6.1344. [DOI] [PubMed] [Google Scholar]
  17. Drexler H., Hayoz D., Münzel T., Hornig B., Just H., Brunner H. R., Zelis R. Endothelial function in chronic congestive heart failure. Am J Cardiol. 1992 Jun 15;69(19):1596–1601. doi: 10.1016/0002-9149(92)90710-g. [DOI] [PubMed] [Google Scholar]
  18. Dunselman P. H., Kuntze C. E., van Bruggen A., Hamer J. P., Scaf A. H., Wessling H., Lie K. I. Efficacy of felodipine in congestive heart failure. Eur Heart J. 1989 Apr;10(4):354–364. doi: 10.1093/oxfordjournals.eurheartj.a059493. [DOI] [PubMed] [Google Scholar]
  19. Dzau V. J., Colucci W. S., Hollenberg N. K., Williams G. H. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 1981 Mar;63(3):645–651. doi: 10.1161/01.cir.63.3.645. [DOI] [PubMed] [Google Scholar]
  20. Elborn J. S., Stanford C. F., Nicholls D. P. Effect of flosequinan on exercise capacity and symptoms in severe heart failure. Br Heart J. 1989 Apr;61(4):331–335. doi: 10.1136/hrt.61.4.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Elkayam U., Amin J., Mehra A., Vasquez J., Weber L., Rahimtoola S. H. A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure. Circulation. 1990 Dec;82(6):1954–1961. doi: 10.1161/01.cir.82.6.1954. [DOI] [PubMed] [Google Scholar]
  22. Ellenbogen K. A., Mohanty P. K., Szentpetery S., Thames M. D. Arterial baroreflex abnormalities in heart failure. Reversal after orthotopic cardiac transplantation. Circulation. 1989 Jan;79(1):51–58. doi: 10.1161/01.cir.79.1.51. [DOI] [PubMed] [Google Scholar]
  23. Fagard R., Lijnen P., Moerman E., Staessen J., Amery A. Acute haemodynamic and humoral responses to felodipine and metoprolol in mild hypertension. Eur J Clin Pharmacol. 1987;32(1):71–75. doi: 10.1007/BF00609960. [DOI] [PubMed] [Google Scholar]
  24. Fitchett D. H., Simkus G. J., Beaudry J. P., Marpole D. G. Reflected pressure waves in the ascending aorta: effect of glyceryl trinitrate. Cardiovasc Res. 1988 Jul;22(7):494–500. doi: 10.1093/cvr/22.7.494. [DOI] [PubMed] [Google Scholar]
  25. Floras J. S. Sympathoinhibitory effects of atrial natriuretic factor in normal humans. Circulation. 1990 Jun;81(6):1860–1873. doi: 10.1161/01.cir.81.6.1860. [DOI] [PubMed] [Google Scholar]
  26. Fowler M. B., Laser J. A., Hopkins G. L., Minobe W., Bristow M. R. Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response. Circulation. 1986 Dec;74(6):1290–1302. doi: 10.1161/01.cir.74.6.1290. [DOI] [PubMed] [Google Scholar]
  27. Franciosa J. A., Jordan R. A., Wilen M. M., Leddy C. L. Minoxidil in patients with chronic left heart failure: contrasting hemodynamic and clinical effects in a controlled trial. Circulation. 1984 Jul;70(1):63–68. doi: 10.1161/01.cir.70.1.63. [DOI] [PubMed] [Google Scholar]
  28. Francis G. S., Goldsmith S. R., Cohn J. N. Relationship of exercise capacity to resting left ventricular performance and basal plasma norepinephrine levels in patients with congestive heart failure. Am Heart J. 1982 Oct;104(4 Pt 1):725–731. doi: 10.1016/0002-8703(82)90003-5. [DOI] [PubMed] [Google Scholar]
  29. Francis G. S. Neuroendocrine activity in congestive heart failure. Am J Cardiol. 1990 Oct 2;66(11):33D–39D. doi: 10.1016/0002-9149(90)90474-f. [DOI] [PubMed] [Google Scholar]
  30. Goldsmith S. R., Francis G. S., Cowley A. W., Jr, Levine T. B., Cohn J. N. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol. 1983 Jun;1(6):1385–1390. doi: 10.1016/s0735-1097(83)80040-0. [DOI] [PubMed] [Google Scholar]
  31. Goldstein R. E., Boccuzzi S. J., Cruess D., Nattel S. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. Circulation. 1991 Jan;83(1):52–60. doi: 10.1161/01.cir.83.1.52. [DOI] [PubMed] [Google Scholar]
  32. Gottlieb S. S., Kukin M. L., Ahern D., Packer M. Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol. 1989 Jun;13(7):1534–1539. doi: 10.1016/0735-1097(89)90344-6. [DOI] [PubMed] [Google Scholar]
  33. Greenberg S., Touhey B., Paul J. Effect of flosequinan (BTS 49465) on myocardial oxygen consumption. Am Heart J. 1990 Jun;119(6):1355–1366. doi: 10.1016/s0002-8703(05)80186-3. [DOI] [PubMed] [Google Scholar]
  34. Hampton J. R. Assessing drugs for the treatment of heart failure. Am J Med. 1991 May 29;90(5B):30S–35S. doi: 10.1016/0002-9343(91)90271-x. [DOI] [PubMed] [Google Scholar]
  35. Hampton J. R., Cowley A. J. Perspectives of drug therapy in heart failure. Eur Heart J. 1991 Aug;12 (Suppl 100):42–45. doi: 10.1093/eurheartj/12.suppl_c.42. [DOI] [PubMed] [Google Scholar]
  36. Hirooka Y., Takeshita A., Imaizumi T., Suzuki S., Yoshida M., Ando S., Nakamura M. Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure. Circulation. 1990 Jul;82(1):147–153. doi: 10.1161/01.cir.82.1.147. [DOI] [PubMed] [Google Scholar]
  37. Joshi P. I., Dalal J. J., Ruttley M. S., Sheridan D. J., Henderson A. H. Nifedipine and left ventricular function in beta-blocked patients. Br Heart J. 1981 Apr;45(4):457–459. doi: 10.1136/hrt.45.4.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Kass D. A., Beyar R. Evaluation of contractile state by maximal ventricular power divided by the square of end-diastolic volume. Circulation. 1991 Oct;84(4):1698–1708. doi: 10.1161/01.cir.84.4.1698. [DOI] [PubMed] [Google Scholar]
  39. Kassis E., Amtorp O. Long-term clinical, hemodynamic, angiographic, and neurohumoral responses to vasodilation with felodipine in patients with chronic congestive heart failure. J Cardiovasc Pharmacol. 1990 Mar;15(3):347–352. doi: 10.1097/00005344-199003000-00001. [DOI] [PubMed] [Google Scholar]
  40. Katzman P. L., Hulthén U. L., Hökfelt B. The effect of 8 weeks treatment with the calcium antagonist felodipine on blood pressure, heart rate, working capacity, plasma renin activity, plasma angiotensin II, urinary catecholamines and aldosterone in patients with essential hypertension. Br J Clin Pharmacol. 1986 Jun;21(6):633–640. doi: 10.1111/j.1365-2125.1986.tb05227.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Kleber F. X., Niemöller L., Doering W. Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial. Br Heart J. 1992 Apr;67(4):289–296. doi: 10.1136/hrt.67.4.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Kleber F. X. Treatment of chronic congestive heart failure. N Engl J Med. 1992 Apr 30;326(18):1220–1221. [PubMed] [Google Scholar]
  43. Kubo S. H., Gollub S., Bourge R., Rahko P., Cobb F., Jessup M., Brozena S., Brodsky M., Kirlin P., Shanes J. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group. Circulation. 1992 Mar;85(3):942–949. doi: 10.1161/01.cir.85.3.942. [DOI] [PubMed] [Google Scholar]
  44. Latson T. W., Hunter W. C., Katoh N., Sagawa K. Effect of nitroglycerin on aortic impedance, diameter, and pulse-wave velocity. Circ Res. 1988 May;62(5):884–890. doi: 10.1161/01.res.62.5.884. [DOI] [PubMed] [Google Scholar]
  45. Leenen F. H., Holliwell D. L. Antihypertensive effect of felodipine associated with persistent sympathetic activation and minimal regression of left ventricular hypertrophy. Am J Cardiol. 1992 Mar 1;69(6):639–645. doi: 10.1016/0002-9149(92)90156-s. [DOI] [PubMed] [Google Scholar]
  46. Levine B., Kalman J., Mayer L., Fillit H. M., Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990 Jul 26;323(4):236–241. doi: 10.1056/NEJM199007263230405. [DOI] [PubMed] [Google Scholar]
  47. Mann D. L., Kent R. L., Parsons B., Cooper G., 4th Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992 Feb;85(2):790–804. doi: 10.1161/01.cir.85.2.790. [DOI] [PubMed] [Google Scholar]
  48. Massie B. M., Conway M., Rajagopalan B., Yonge R., Frostick S., Ledingham J., Sleight P., Radda G. Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. Circulation. 1988 Aug;78(2):320–326. doi: 10.1161/01.cir.78.2.320. [DOI] [PubMed] [Google Scholar]
  49. McMurray J., Abdullah I., Dargie H. J., Shapiro D. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J. 1991 Nov;66(5):356–358. doi: 10.1136/hrt.66.5.356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Northridge D. B., Jardine A. G., Findlay I. N., Archibald M., Dilly S. G., Dargie H. J. Inhibition of the metabolism of atrial natriuretic factor causes diuresis and natriuresis in chronic heart failure. Am J Hypertens. 1990 Sep;3(9):682–687. doi: 10.1093/ajh/3.9.682. [DOI] [PubMed] [Google Scholar]
  51. Ontkean M., Gay R., Greenberg B. Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. Circ Res. 1991 Oct;69(4):1088–1096. doi: 10.1161/01.res.69.4.1088. [DOI] [PubMed] [Google Scholar]
  52. Packer M., Carver J. R., Rodeheffer R. J., Ivanhoe R. J., DiBianco R., Zeldis S. M., Hendrix G. H., Bommer W. J., Elkayam U., Kukin M. L. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med. 1991 Nov 21;325(21):1468–1475. doi: 10.1056/NEJM199111213252103. [DOI] [PubMed] [Google Scholar]
  53. Packer M., Kessler P. D., Lee W. H. Calcium-channel blockade in the management of severe chronic congestive heart failure: a bridge too far. Circulation. 1987 Jun;75(6 Pt 2):V56–V64. [PubMed] [Google Scholar]
  54. Parker K. H., Jones C. J. Forward and backward running waves in the arteries: analysis using the method of characteristics. J Biomech Eng. 1990 Aug;112(3):322–326. doi: 10.1115/1.2891191. [DOI] [PubMed] [Google Scholar]
  55. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  56. Poole-Wilson P. A., Buller N. P., Lipkin D. P. Regional blood flow, muscle strength and skeletal muscle histology in severe congestive heart failure. Am J Cardiol. 1988 Sep 9;62(8):49E–52E. doi: 10.1016/s0002-9149(88)80011-0. [DOI] [PubMed] [Google Scholar]
  57. Richards A. M., Cleland J. G., Tonolo G., McIntyre G. D., Leckie B. J., Dargie H. J., Ball S. G., Robertson J. I. Plasma alpha natriuretic peptide in cardiac impairment. Br Med J (Clin Res Ed) 1986 Aug 16;293(6544):409–412. doi: 10.1136/bmj.293.6544.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Sasayama S., Asanoi H. Coupling between the heart and arterial system in heart failure. Am J Med. 1991 May 29;90(5B):14S–18S. doi: 10.1016/0002-9343(91)90267-2. [DOI] [PubMed] [Google Scholar]
  59. Schuler G., Hambrecht R., Schlierf G., Niebauer J., Hauer K., Neumann J., Hoberg E., Drinkmann A., Bacher F., Grunze M. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation. 1992 Jul;86(1):1–11. doi: 10.1161/01.cir.86.1.1. [DOI] [PubMed] [Google Scholar]
  60. Schuler G., Hambrecht R., Schlierf G., Niebauer J., Hauer K., Neumann J., Hoberg E., Drinkmann A., Bacher F., Grunze M. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation. 1992 Jul;86(1):1–11. doi: 10.1161/01.cir.86.1.1. [DOI] [PubMed] [Google Scholar]
  61. Schuler G., Hambrecht R., Schlierf G., Niebauer J., Hauer K., Neumann J., Hoberg E., Drinkmann A., Bacher F., Grunze M. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation. 1992 Jul;86(1):1–11. doi: 10.1161/01.cir.86.1.1. [DOI] [PubMed] [Google Scholar]
  62. Schuler G., Hambrecht R., Schlierf G., Niebauer J., Hauer K., Neumann J., Hoberg E., Drinkmann A., Bacher F., Grunze M. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation. 1992 Jul;86(1):1–11. doi: 10.1161/01.cir.86.1.1. [DOI] [PubMed] [Google Scholar]
  63. Schuler G., Hambrecht R., Schlierf G., Niebauer J., Hauer K., Neumann J., Hoberg E., Drinkmann A., Bacher F., Grunze M. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation. 1992 Jul;86(1):1–11. doi: 10.1161/01.cir.86.1.1. [DOI] [PubMed] [Google Scholar]
  64. Schuler G., Hambrecht R., Schlierf G., Niebauer J., Hauer K., Neumann J., Hoberg E., Drinkmann A., Bacher F., Grunze M. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation. 1992 Jul;86(1):1–11. doi: 10.1161/01.cir.86.1.1. [DOI] [PubMed] [Google Scholar]
  65. Schuler G., Hambrecht R., Schlierf G., Niebauer J., Hauer K., Neumann J., Hoberg E., Drinkmann A., Bacher F., Grunze M. Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease. Circulation. 1992 Jul;86(1):1–11. doi: 10.1161/01.cir.86.1.1. [DOI] [PubMed] [Google Scholar]
  66. Sinoway L. I., Minotti J. R., Davis D., Pennock J. L., Burg J. E., Musch T. I., Zelis R. Delayed reversal of impaired vasodilation in congestive heart failure after heart transplantation. Am J Cardiol. 1988 May 1;61(13):1076–1079. doi: 10.1016/0002-9149(88)90129-4. [DOI] [PubMed] [Google Scholar]
  67. Steffen R. P., de la Mata M. The effects of I5AU8I, a chemically stable prostacyclin analog, on the cardiovascular and renin-angiotensin systems of anesthetized dogs [corrected]. Prostaglandins Leukot Essent Fatty Acids. 1991 Aug;43(4):277–286. doi: 10.1016/0952-3278(91)90043-5. [DOI] [PubMed] [Google Scholar]
  68. Swedberg K., Eneroth P., Kjekshus J., Snapinn S. Effects of enalapril and neuroendocrine activation on prognosis in severe congestive heart failure (follow-up of the CONSENSUS trial). CONSENSUS Trial Study Group. Am J Cardiol. 1990 Oct 2;66(11):40D–45D. doi: 10.1016/0002-9149(90)90475-g. [DOI] [PubMed] [Google Scholar]
  69. Swedberg K., Eneroth P., Kjekshus J., Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation. 1990 Nov;82(5):1730–1736. doi: 10.1161/01.cir.82.5.1730. [DOI] [PubMed] [Google Scholar]
  70. Tan L. B., Jalil J. E., Pick R., Janicki J. S., Weber K. T. Cardiac myocyte necrosis induced by angiotensin II. Circ Res. 1991 Nov;69(5):1185–1195. doi: 10.1161/01.res.69.5.1185. [DOI] [PubMed] [Google Scholar]
  71. Thomas P., Sheridan D. J. Vascular selectivity of felodipine: clinical experience. J Cardiovasc Pharmacol. 1990;15 (Suppl 4):S17–S20. doi: 10.1097/00005344-199015004-00004. [DOI] [PubMed] [Google Scholar]
  72. Weber K. T., Brilla C. G. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991 Jun;83(6):1849–1865. doi: 10.1161/01.cir.83.6.1849. [DOI] [PubMed] [Google Scholar]
  73. Yaginuma T., Avolio A., O'Rourke M., Nichols W., Morgan J. J., Roy P., Baron D., Branson J., Feneley M. Effect of glyceryl trinitrate on peripheral arteries alters left ventricular hydraulic load in man. Cardiovasc Res. 1986 Feb;20(2):153–160. doi: 10.1093/cvr/20.2.153. [DOI] [PubMed] [Google Scholar]
  74. Yates D. B. Pharmacology of flosequinan. Am Heart J. 1991 Mar;121(3 Pt 1):974–983. doi: 10.1016/0002-8703(91)90229-b. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES